DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Household
Author Program NEWCreate Narrative
CL logo

Colgate-Palmolive Company Stock Price

NYSE:CL Community·US$70.5b Market Cap
  • 2 Narratives written by author
  • 0 Comments on narratives written by author
  • 176 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CL Share Price Performance

US$88.03
4.83 (5.81%)
​
US$98.95
Fair Value
US$88.03
4.83 (5.81%)
11.0% undervalued intrinsic discount
US$98.95
Fair Value
Price US$88.03
AnalystConsensusTarget US$98.95
rcb9 US$86.48
Tue, 4 Aug 26
Fair ValueUS$98.95
Share Pricen/a

CL Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$98.95 11.0% undervalued intrinsic discount

CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds

1users have liked this narrative
0users have commented on this narrative
85users have followed this narrative
RC
rcb9's
Fair Value
·
Fair Value US$86.48 1.8% overvalued intrinsic discount

The Ten Percent Margin Is A Write Down, Not The Business

0users have liked this narrative
0users have commented on this narrative
8users have followed this narrative
CL logo
Colgate-Palmolive
1.8% overvalued intrinsic discount

The Ten Percent Margin Is A Write Down, Not The Business

View narrative
RC
Emerging Author
rcb9
Published 3 Aug
Read Narrative
CL logo
Colgate-Palmolive
11.0% undervalued intrinsic discount

CL: Future Cost Optimization Will Drive Competitive Advantage Amid Category Headwinds

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 4 Aug
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

RC
CL logo

The Ten Percent Margin Is A Write Down, Not The Business

Fair Value: US$86.48 1.8% overvalued intrinsic discount
8 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
CL logo

CL: International Execution And Pet Nutrition Will Offset 2026 Margin Pressures

Fair Value: US$98.95 11.0% undervalued intrinsic discount
85 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Established dividend payer with mediocre balance sheet.

3 Risks
3 Rewards
View Full Analysis

Colgate-Palmolive Company Key Details

US$21.0b

Revenue

US$8.3b

Cost of Revenue

US$12.7b

Gross Profit

US$10.7b

Other Expenses

US$2.0b

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 30, 2026
2.56
60.43%
9.68%
1,388.2%
View Full Analysis

About CL

Founded
1806
Employees
33600
CEO
Noel Wallace
WebsiteView website
www.colgatepalmolive.com

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under the Colgate, Palmolive, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline, and Suavitel brands to a range of traditional and eCommerce retailers, wholesalers, and distributors, as well as dentists and skin health professionals. It also offers pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill’s Science Diet brand; and a range of therapeutic pet products to help nutritionally support dogs and cats in different stages of health under the Hill’s Prescription Diet brand; and a fresh pet food sold to pet specialty and other retailers in Australia under Prime100 brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Recent CL News & Updates

Seeking Alpha • Sep 02

Colgate-Palmolive: Don't Ignore This Resilient Dividend King

Summary Colgate-Palmolive remains a Buy, offering defensive qualities, a resilient global portfolio, and an attractive margin of safety at current valuation. Q2 results showed 4.9% net sales growth and 8% base EPS growth, with strong performance outside North America and continued innovation driving market share gains. CL maintains robust free cash flow, supports a 2.36% dividend yield, and continues share repurchases, underpinned by manageable debt and disciplined capital allocation. Risks include macroeconomic headwinds, rising raw material costs, and private label competition, but CL’s global presence and market penetration support long-term growth potential. Read the full article on Seeking Alpha
User avatar
Narrative Update • Aug 04

CL: International Execution And Pet Nutrition Will Offset 2026 Margin Pressures

Analysts have nudged their fair value estimate for Colgate-Palmolive higher from about $96.68 to roughly $98.95. This reflects updated price targets that highlight solid profit execution, resilient international growth and model tweaks after recent quarterly results.

Recent updates

No updates

Colgate-Palmolive Company Competitors

PG logo

Procter & Gamble

Symbol: NYSE:PG
Market cap: US$338.1b
EL logo

Estée Lauder Companies

Symbol: NYSE:EL
Market cap: US$36.8b
KVUE logo

Kenvue

Symbol: NYSE:KVUE
Market cap: US$35.3b
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide